Keep an eye on XBL. Trying to break up from multi year base. Has...

Keep an eye on XBL. Trying to break up from multi year base. Has about 10-11c cash per share. New CEO - Ex Metabolic, Axon and Circadian.
Have been in exclusive negotiations with a major about their fully biodegradable stents. (Opens up arteries then once healed they biodegrade into natural compounds the body can absorb - better alternative to open heart surgery). This period is due to expire in November so I guess watch for insiders buying closer to mid-November.